Immunological Research Tools

An effective immune system is critical for a complex organism’s health and survival. ATCC supplies a wide variety of cultures, reagents, and services useful for this important area of research.


The immune system has cellular components which functionally interact to protect against foreign invaders such as bacteria and viruses. ATCC provides numerous cell lines, microbial pathogens, cell culture reagents, and non-cellular immunogens focused on advancing immunological research areas, including antigen presentation, lymphocyte maturation, vaccine production, T cell suppression, and liquid tumor cancers. The ATCC collection includes:


  • Viruses, bacteria, fungi, protozoa
  • Polysaccharides, nucleic acids, toxins
  • Cancer immunology
  • Natural killer cells
    • Check out the resources below to learn more.

      Bone Marrow and Blood

      Bone Marrow Cells
      Blood Cells

      ATCC houses a vast collection of cell lines derived from the bone marrow cells of multiple species, representing a variety of immunological cells. These cells originate in the bone marrow and then may migrate into blood circulation, lymphatic circulation, and lymphatic tissues. They are classified as either bone marrow or blood tissue depending on the source of isolation.

      Natural Killer Cells

      Natural Killer Cells

      Measuring the activity of natural killer cells is necessary for many immune applications. ATCC’s Human Primary CD56+ NK Cells provide researchers with a physiologically relevant and highly validated source of natural killer cells for cytotoxic killing activity assays. Combined with ATCC’s K-562-GFP cells, scientists can perform cytotoxicity assays with no upstream preparation in a manner which addresses the drawbacks of previous methods.

      Cancer Immunology Research Tools

      Cancer Immunology Research Tools

      Boost your cancer immunology research with cell lines and cell culture reagents focused on advancing areas such as cancer cell-directed therapies and immune cell-directed therapies. Our collection of primary cells and continuous cell lines includes immune cells, CD34+ and CD14+ progenitor cells, primary mononuclear cells, lymphocytes, and leukocytes.